PROFICIENCY TESTING 2013 - FAVV-AFSCA€¦ · CODACODA- ---CERVACERVA 172-PT PT2013PTUSER 2/24 This report can’t be reproduced, except in complete form, without the permission of

PT2013PTUSER 1/24 This report can’t be reproduced, except in complete form, without the permission of the CODA-CERVA: CVD-ERA

CODACODACODACODA----CERVACERVACERVACERVA

Veterinary and Agrochemical Research Centre

Groeselenberg 99 – B 1180 Brussels (Ukkel)

Tel: +32 (0)2 379 04 11

Fax : + 32 (0)2 379 06 70

http: // www.coda-cerva.be

172-PT

PROFICIENCY TESTING 2013

Paratuberculosis (PTU)

Detection of PTU-specific antibodies in bovine serum and/or

bovine milk by Enzyme Linked Immunosorbent Assay (ELISA)

OPERATIONAL UNIT

COORDINATION OF VETERINARY DIAGNOSIS

EPIDEMIOLOGY AND RISK ASSESSMENT

(CVD-ERA)

DATE BEGIN PT: 18 NOVEMBER 2013

DATE REPORT: 03 MARCH 2014


172-PT


I. Introduction Details relevant to the proficiency test (PT) are available in the Procedure PRO/2.5/01 ‘Beheer van de proficiency testen op het CODA-CERVA-Ukkel/Gestion des essais d’aptitude au CODA-CERVA-Uccle’, which is summarized in the ‘Manual for the participant’. II. Aim The aim of this PT was to evaluate the ability of the participating laboratories to identify the absence or presence of PTU-specific antibodies in bovine serum and/or bovine milk by ELISA. III. Materials and methods III.1. Conduct of diagnostic tests In the framework of this PT, predefined reference serum and/or reference milk samples must be analyzed by means of a PTU antibody ELISA test. The procedures for these ELISA tests must be fully described in the SOPs of the participating laboratories.

III.2. Reference samples III.2.1. Reference serum samples

Replicates of 6 reference serum samples of bovine origin, either free from detectable PTU-specific antibodies (n = 3; coded ‘PT2013PTUSERNS1’, ‘PT2013PTUSERNS2’ and ‘PT2013PTUSERNS3’) or containing detectable PTU-specific antibodies (n = 3; coded ‘PT2013PTUSERPS1’, ‘PT2013PTUSERPS2’ and ‘PT2013PTUSERPS3’), were used. In total, 140 aliquots were distributed to 7 participating laboratories. All participants received 20 aliquots: 3 aliquots of the reference serum samples PT2013PTUSERNS1, PT2013PTUSERNS2, PT2013PTUSERNS3 and PT2013PTUSERPS1, and 4 aliquots of the reference serum samples PT2013PTUSERPS2 and PT2013PTUSERPS3. The positions of the reference serum samples in the sent blocks were randomized for each participant (Table 4). For each reference serum sample, a certificate containing the status of the sample (= ‘golden standard’) was made. The status of the reference serum samples was based on (i) the historical background of the animals and (ii) the results obtained by the Pourquier® ELISA Paratuberculosis Screening Antibody Test Kit from IDEXX Montpellier SAS and the ID Screen® Paratuberculosis Indirect Screening antibody ELISA test kit from IDVET (pre-verification). The reference serum samples PT2013PTUSERNS1, PT2013PTUSERNS2 and PT2013PTUSERNS3 were PTU antibody negative field sera, and the reference serum samples PT2013PTUSERPS1, PT2013PTUSERPS2 and PT2013PTUSERPS3 were PTU antibody positive field sera from 3 different animals. For 2 of these samples (PT2013PTUSERP1 and PT2013PTUSERPS2) the animals were shown to be shedders by PCR analysis on faeces samples. For each reference serum sample, the same qualitative result was obtained with both ELISA kits used. Taken together, the reference serum samples PT2013PTUSERNS1, PT2013PTUSERNS2 and PT2013PTUSERNS3 were considered as negative sera, and the reference serum samples PT2013PTUSERPS1, PT2013PTUSERPS2 and PT2013PTUSERPS3 were considered as positive sera.. After aliquoting the different reference serum samples, a homogeneity check was performed on 10 aliquots of each reference serum sample using the Pourquier® ELISA Paratuberculosis Screening Antibody Test Kit from IDEXX Montpellier SAS and the ID Screen® Paratuberculosis Indirect Screening antibody ELISA test kit from IDVET, hereby obtaining the same qualitative result for all 10 aliquots of the same reference serum sample with both ELISA kits. Consequently, all reference serum samples were considered as reliable samples in order to evaluate the ability of laboratories to correctly identify the absence or presence of PTU-specific antibodies in bovine serum. In addition, 3 alliquots of each reference serum sample were tested after the PT in order to confirm their stability and status (post-verification) using the Pourquier® ELISA Paratuberculosis Screening Antibody Test Kit from IDEXX Montpellier SAS and the ID Screen® Paratuberculosis Indirect Screening antibody ELISA test kit from IDVET.


172-PT


III.2.2. Reference milk samples

Replicates of 6 reference milk samples of bovine origin, either free from detectable PTU-specific antibodies (n = 3; coded ‘PT2013PTUSERNM1’, ‘PT2013PTUSERNM2’ and ‘PT2013PTUSERNM3’) or containing detectable PTU-specific antibodies (n = 3; coded ‘PT2013PTUSERPM1’, ‘PT2013PTUSERPM2’, and ‘PT2013PTUSERPM3’), were used. In total, 140 aliquots were distributed to 7 participating laboratories. All participants received 20 aliquots: 3 aliquots of the reference milk samples PT2013PTUSERNM1, PT2013PTUSERNM2, PT2013PTUSERNM3 and PT2013PTUSERPM1, , and 4 aliquots of the reference milk samples PT2013PTUSERPM2 and PT2013PTUSERPM3. The positions of the reference milk samples in the sent blocks were randomized for each participant (Table 5). For each reference milk sample, a certificate containing the status of the sample (= ‘golden standard’) was made. The status of the reference milk samples was based on (i) the historical background of the animals and (ii) the results obtained by the IDEXX Paratuberculosis Screening Ab Test kit from IDEXX Montpellier SAS and the ID Screen® Paratuberculosis Indirect Screening antibody ELISA test kit from IDVET (pre-verification). The reference milk samples PT2013PTUSERNM1, PT2013PTUSERNM2 and PT2013PTUSERNM3 were derived from 3 different brands of commercial defatted milk, whereas the reference milk samples PT2013PTUSERPM1, PT2013PTUSERPM2 and PT2013PTUSERPM3 were obtained from animals that were PTU antibody positive. For each reference milk sample, the same qualitative result was obtained with both ELISA kits used. Taken together, the reference milk samples PT2013PTUSERNM1, PT2013PTUSERNM2 and PT2013PTUSERNM3 were considered as negative milk samples, and the reference milk samples PT2013PTUSERPM1, PT2013PTUSERPM2 and PT2013PTUSERPM3 as positive milk samples. After aliquoting the different reference milk samples, a homogeneity check was performed on 10 aliquots of each reference milk sample using the IDEXX Paratuberculosis Screening Ab Test kit from IDEXX Montpellier SAS and the ID Screen® Paratuberculosis Indirect Screening antibody ELISA test kit from IDVET, hereby obtaining the same qualitative result for all 10 aliquots of the same reference milk sample with both ELISA kits. Consequently, all reference milk samples were considered as reliable samples in order to evaluate the ability of laboratories to correctly identify the absence or presence of PTU-specific antibodies in bovine milk. In addition, 3 alliquots of each, reference milk sample were tested once after the PT in order to confirm their stability and status (post-verification) using the IDEXX Paratuberculosis Screening Ab Test kit from IDEXX Montpellier SAS and the ID Screen® Paratuberculosis Indirect Screening antibody ELISA test kit from IDVET.

III.3. Classification of results, level of agreement and threshold for qualification III.3.1. Classification of results

Results provided by the participating laboratories are categorized as success when the reported result matches with the assigned status or failure when the reported result does not match with the assigned status. III.3.2. Level of agreement

The level of agreement achieved by the participating laboratories is expressed as the percentage of success for the 20 aliquots of reference samples used for either PT. III.3.3. Threshold for qualification

Following the procedure, a participating laboratory is only qualified if the level of agreement for the 20 aliquots of reference samples used for either PT is at least 90%. IV. Results For confidentiality reasons, the participating laboratories are quoted anonymously and the concordance table is safely kept at the operational unit CVD-ERA of CODA-CERVA.


172-PT


IV.1. Transfer and start of the analyses of the reference samples LAB1, LAB2, LAB3 and LAB4 participated in both the PT serum and the PT milk and hence received 40 aliquots: 20 aliquots of reference serum samples and 20 aliquots of reference milk samples. In contrast, LAB5, LAB6, and LAB7 only participated in the PT serum and hence received 20 aliquots of reference serum samples, whereas LAB8, LAB9 and LAB10 only participated in the PT milk and thus received 20 aliquots of reference milk samples. The reference serum samples (140 aliquots in total) and reference milk samples (140 aliquots in total) were sent frozen (dry ice) to the 10 participating laboratories by national or international courier on the 18th of November 2013. LAB3, LAB4, LAB5, LAB6, LAB8, LAB9 and LAB10 acknowledged receipt of the samples on the same day, whereas the other participants acknowledged receipt of the samples on 19th (LAB7) and 20th (LAB1 and LAB2) of November 2013. Analyses were performed between 19th of November and 5th of December 2013, both for the PT serum and the PT milk (Table 1).

IV.2. Dates at which results were returned to the operational unit CVD-ERA Results were submitted to the operational unit CVD-ERA between 21th of November and 9th of December 2013 (Table 1). LAB4 exceeded the deadline of 6th of December 2013 for submission of the results. Table 1. Overview of the dates on which (i) the reference samples were received and analyzed by the participating laboratories, and (ii) the obtained results were submitted to the operational unit CVD-ERA of CODA-CERVA.

Laboratory Reference samples received

Start of analysis serum

Start of analysis milk

Submission of the results (Excel file)

LAB1 20/11/2013 5/12/2013 5/12/2013 06/12/2013

LAB2 20/11/2013 5/12/2013 4/12/2013 06/12/2013

LAB3 18/11/2013 25/11/2013 25/11/2013 25/11/2013

LAB4 18/11/2013 20/11/2013 20/11/2013 21/11/2013

LAB5 18/11/2013 19/11/2013 NA 05/12/2013

LAB6 18/11/2013 19/11/2013 NA 27/11/2013

LAB7 19/11/2013 21/11/2013 NA 05/12/2013

LAB8 18/11/2013 NA 19/11/2013 27/11/2013

LAB9 18/11/2013 NA 21/11/2013 05/12/2013

LAB10 18/11/2013 NA 3/12/2013 09/12/2013

Legend: NA = not applicable

IV.3. Compliance with the procedure Four out of 10 participating laboratories have provided a duly dated and signed copy of the results.

IV.4. Qualitative data analysis IV.4.1. Level of agreement

Qualitative data analysis showed that:

(i) For the detection of PTU-specific antibodies in serum , 5 out of 7 participating laboratories provided qualitative results that were in full agreement with the true status of the reference serum samples and thus achieved 100% of agreement. LAB3 misclassified 1 reference serum samples and hence reached 95% of agreement and LAB5 misclassified 6 reference serum samples and hence reached 70% of agreement (Table 2).

(ii) For the detection of PTU-specific antibodies in milk , 5 out of 7 participating laboratories provided qualitative results that were in full agreement with the true status of the reference milk samples and thus achieved 100% of


172-PT


agreement. LAB3 and LAB9 misclassified 4 reference milk samples and hence reached 80% of agreement and (Table 3).

A quantitative data analysis (including box plots) is shown for educational purposes in Annex 1 and Annex 2. Table 2. Agreement between results generated by the participating laboratories (LABNR) and the status of the reference serum samples assigned by the PTU reference laboratory of CODA-CERVA. All participating laboratories received 20 aliquots of reference serum samples. Results are presented as absolute values and percentages (in parentheses).

LABNR

1 2 3 4 5 6 7

failure 0 ( 0.0) 0 ( 0.0) 1 ( 5.0) 0 ( 0.0) 6 (30.0) 0 ( 0.0) 0 ( 0.0)

success 20 (100.) 20 (100.) 19 (95.0) 20 (100.) 14 (70.0) 20 (100.) 20 (100.)

Table 3. Agreement between results generated by the participating laboratories (LABNR) and the status of the reference milk samples assigned by the PTU reference laboratory of CODA-CERVA. All participating laboratories received 20 aliquots of reference milk samples. Results are presented as absolute values and percentages (in parentheses).

LABNR

1 2 3 4 8 9* 10

failure 0 ( 0.0) 0 ( 0.0) 4 (20.0) 0 ( 0.0) 0 ( 0.0) 4 (20.0) 0 ( 0.0)

success 20 (100.) 20 (100.) 16 (80.0) 20 (100.) 20 (100.) 16 (80.0) 20 100.)

*If LAB9 used the cut off foreseen by te manufacturer the percentage of agreement will be 100% and all alliquots of sample PT2013PTUSERPM3 will be interpretated as positive.

IV.4.2. Variability among participating laboratories

Only a small variability between laboratories could be observed at the qualitative data level:

(i) For the detection of PTU-specific antibodies in reference serum samples, no variability between qualitative laboratory results could be observed for LAB1, LAB2, LAB4, LAB6 and LAB7 since these participants correctly identified all reference serum samples. In contrast, LAB3 misclassified 1 out of 4 aliquots of the positive reference serum sample PT2013PTUSERPS2 (NI instead of POS) and LAB5 misclassified all aliquots of the positive reference serum samples PT2013PTUSERPS2 (4x NEG instead of POS) and 2 out of 4 aliquots of the positive reference serum sample PT2013PTUSERPS3 (2x NI instead of POS).

(ii) For the detection of PTU-specific antibodies in reference milk samples, no variability between qualitative laboratory results could be observed for LAB1, LAB2, LAB4, LAB8 and LAB10 since these participants correctly identified all reference milk samples. In contrast, LAB3 and LAB9 misclassified all aliquots of the positive reference milk samples PT2013PTUSERPM3 (4x NI instead of POS).

For each participating laboratory, the obtained results and the assigned statuses for the reference samples are shown in Table 4 for the PT serum and in Table 5 for the PT milk.


172-PT


Table 4. The responses (RESULT) of the participating laboratories (LABNR) with the identification of the reference serum samples (SAMPLE), the positions of the reference serum samples as placed in the block (LABPOSIT), and the status assigned by the PTU reference laboratory of CODA-CERVA (STATUS). NEG: negative; POS: positive; NI: non-interpretable.

LABNR LABPOSIT SAMPLE STATUS RESULT SUCCESS

1 1 1 PT2013PTUSERNS1 NEG NEG 1

2 1 2 PT2013PTUSERPS1 POS POS 1








































172-PT


(Table 4 - CONTINUED)











50 3 10 PT2013PTUSERPS2 POS NI 0
































172-PT









86 5 6 PT2013PTUSERPS2 POS NEG 0




































172-PT

























172-PT


Table 5. The responses (RESULT) of the participating laboratories (LABNR) with the identification of the reference milk samples (SAMPLE), the positions of the reference milk samples as placed in the block (LABPOSIT), and the status assigned by the PTU reference laboratory of CODA-CERVA (STATUS). NEG: negative; POS: positive.


1 1 1 PT2013PTUSERNM1 NEG NEG 1

2 1 2 PT2013PTUSERPM1 POS POS 1








































172-PT

















54 3 14 PT2013PTUSERPM3 POS NI 0




























172-PT













































172-PT

























172-PT


V. Discussion The purpose of this PT was to assess the performances of the participating laboratories when analyzing reference serum and/or reference milk samples of bovine origin for the detection of PTU-specific antibodies by ELISA. For the detection of PTU-specific antibodies in serum, 5 out of 7 participating laboratories provided qualitative results that were in full agreement with the true status of the reference serum samples (100% of agreement). LAB3 misclassified 1 aliquot of the positive reference serum sample PT2013PTUSERPS2 (95% of agreement) and LAB5 misclassified the 4 aliquots of the positive reference serum sample PT2013PTUSERPS2 and 2 aliquots of the positive reference serum sample PT2013PTUSERPS3 (70% of agreement) (Table 2 and Table 4). For LAB5, the quantitative values of the 4 alliquots of the sample PT2013PTUSERPS2 were far below the lower cut off value of 60% S/P ratio. The participating laboratories used PTU antibody ELISA kits from 4 different producers as well as different kits from the same producer: The IDEXX Paratuberculosis Screening Ab Test Kit was used by LAB1 (batch 2145), the LSIVET Ruminant Paratbuberculosis Advanced (serum) kit was used by LAB2 (batch 5-VETPTRS-025), ID.VET Screen Paratuberculose Indirect kit was used by LAB5 (batch 445) and LAB6 (batch 560) and the Mycobacterium paratbc antibody test kit of IDEXX was used by LAB 3 (batch 3185), LAB4 (batch 2251) and LAB7 (batch 2038). In addition, all these participants performed the short incubation protocol of the used ELISA kit. For the detection of PTU-specific antibodies in milk, 5 out of 7 participating laboratories provided qualitative results that were in full agreement with the true status of the reference milk samples (100% of agreement). LAB3 and LAB9 misclassified the 4 aliquots of the positive reference milk samples PT2013PTUSERPM3 (80% of agreement) (Table 3 and Table 5). For LAB9 this could be due to a different interpretation of the cut off values. LAB9 used a cut off of 30-40% to assign a sample as positive (if S/P ratio > 40%) instead of the cut off of 20-30% as prescribed by the manufacturer. The participating laboratories used PTU antibody ELISA kits from different producers as well as different batches from the same producer: the ID.VET Screening Paratuberculosis Indirect was used by LAB10 (batch 607-021) and LAB8 (batch 445), the IDEXX Paratuberculosis Screening Ab Test was used by LAB1 (batch 2145) and LAB9 (batch 3187), the LSIVet Bovine Paratuberculosis – Milk ELISA was used by LAB2 (Batch 5-PTML-004), the Mycobacterium paratb Antibody Test Kit of IDEXX was used by LAB3 (batch 3185) and LAB4 (batch 2251). VI. Conclusions According to the procedure currently in force, the performance of a participating laboratory is satisfactory if at least 90% of the results provided by this laboratory is in agreement with the status of the reference samples assigned by the PTU reference laboratory of CODA-CERVA (see III.3.3.). Consequently, 6 out of 7 participants in the PT serum achieved a satisfactory performance for the detection of PTU-specific antibodies in reference serum samples, whereas 5 out of 7 participants in the PT milk achieved a satisfactory performance for the detection of PTU-specific antibodies in reference milk samples.

Head CVD-ERA Yves Van der Stede


172-PT


Appendix

Names of the participating laboratories

Association Régionale de Santé et d'Identification Animales (ARSIA) (Ciney, Belgium)

Association Régionale de Santé et d'Identification Animales (ARSIA) (Loncin, Belgium)

Comité du lait (Battice, Belgium)

Dierengezondheidszorg Vlaanderen (DGZ) (Torhout, Belgium)

IDEXX Montpellier SAS (Montpellier, France)

Laboratoire de Médecine Vétérinaire de l’Etat (LMVE) (Grand Duchy of Luxemburg)

Laboratoire Départemental d'Analyses du Tarn (LDA81) (Albi, France)

Laboratoire Service International (LSI) / Life Technologies (Animal Health) (Lissieu, France)

Melkcontrolecentrum Vlaanderen (MCC) (Lier, Belgium)

Veterinary and Agrochemical Research Center (CODA-CERVA) (Ukkel, Belgium)



Annex 1: Quantitative data analysis Besides qualitative data analysis (positive, negative or non-interpretable result), also quantitative data analysis was performed using the statistical software programs SAS 9.2. (summary statistics) and R (box plots). All quantitative analyses were performed on the normalized data, namely the percentages S/P ratio calculated according to the instructions of the PT provider: [(ODSample - mean ODNegative Kit Controls) / (mean ODPositive Kit Controls - mean ODNegative Kit Controls)] *100. The quantitative data analysis in this report was not used to evaluate the participants in this PT, but should only be considered as educational information for the participants in order to evaluate their performance and/or to standardize their different diagnostic tests.

I. Box plots Box plots of the percentages S/P ratio per reference serum sample and per participating laboratory were made using the statistical software R and are shown in Figure 1.

Figure 1. Box plots showing the percentages S/P ratio per reference serum sample and per participating l aboratory. Box plots represent the minimum value, the maximum value, the median, the lower (25%) and upper (75%) quartile, and possible outliers per sample and per laboratory. Cut-off values applied by the participating laboratories are shown in green (45-55%; LAB1,LAB3,LAB4 and LAB7), red (60%, LAB2) and grey (60-70%, LAB5 and LAB6) In addition, all these participants performed the short incubation protocol of the used ELISA kit. The values for sample PT2013PTUSERPS1 obtained by LAB2 were left out since this LAB2 obtained S/P ratio’s that were much higher compared to the other participating laboratories.



Remark: To calculate the percentages S/P ratio, the PT provider used the formula [(ODSample - mean ODNegative Kit Controls) / (mean ODPositive Kit Controls - mean ODNegative Kit Controls)] *100. Because LAB2 calculated the percentages S/P ratio for the milk samples using a different formula [ODSample / mean ODPositive Kit Controls] * 100, the cut-offs for the PTU antibody ELISA kit used by LAB2 were adapted accordingly (54-64% instead of 60-70%).

Figure 2A. Box plots showing the percentages S/P rat io per reference milk sample and per participating laboratory. Box plots represent the minimum value, the maximum value, the median, the lower (25%) and upper (75%) quartile, and possible outliers per sample and per laboratory. Cut-off values applied by the participating laboratories are shown in brown (15%; LAB8 and LAB10), green (20-30%; LAB1, LAB3, LAB4), and pink (30-40%; LAB9), red (54-64%; LAB2). LAB1, LAB3, LAB4, LAB8 and LAB10 used the short protocol while LAB2 used a long incubation protocol.



Figure 2B. Box plots showing the percentages S/P rati o per reference milk sample and per participating l aboratory (without LAB2). Box plots represent the minimum value, the maximum value, the median, the lower (25%) and upper (75%) quartile, and possible outliers per sample and per laboratory. II. Mandel’s h- and k-statistics (z-scores) Based on ISO 5725-2 and ISO 13528, between-lab variability (reproducibility) and within-lab variability (repeatability) were estimated through Mandel’s h- and k-statistics, respectively, using the statistical software SAS 9.2. Mandel’s h- and k-statistics were calculated based on the percentages S/P ratio per reference serum/milk sample and per participating laboratory. Remark: For the PT milk, LAB2 calculated percentages S/P ratio using a weak positive kit control whereas the other partipating laboratories used a strong positive kit control. Consequently, LAB2 obtained percentages S/P ratio that were much higher compared to the other participants. In order to avoid bias of the comparative quantitative data analysis, data from LAB2 were not included in the calculation of Mandel’s h- and k-statistics for the PT milk. The h-statistic depends on the number of participants, whereas the k-statistic depends on both the number of participants and the number of repeats per sample. When 30 participants or more are involved in a PT, a satisfactory between-lab and within-lab consistency is obtained when the (absolute) value for the h- and k-statistic is smaller than 2. An unsatisfactory result (a corrective action is required) is reached when the (absolute) value is larger than 3. (Absolute) values between 2 and 3 indicate a questionable consistency. Importantly, in case of a smaller number of participants (which is the case in this PT), other indicator values apply for Mandel’s h- and k-statistics (Table 1).



Table 1. Indicators for Mandel’s h- and k-statistics at the 5% significance level in function of the number of participating laboratories (p) and the number of repeats per sample (n) as described in ISO 5725-2.

p (# labs) h

k

n (# repeats)

2 3 4 5 6 7 8 9 10

3 1,15 1,65 1,53 1,45 1,40 1,37 1,34 1,32 1,30 1,29

4 1,42 1,76 1,59 1,50 1,44 1,40 1,37 1,35 1,33 1,31

5 1,57 1,81 1,62 1,53 1,46 1,42 1,39 1,36 1,34 1,32

6 1,66 1,85 1,64 1,54 1,48 1,43 1,40 1,37 1,35 1,33

7 1,71 1,87 1,66 1,55 1,49 1,44 1,41 1,38 1,36 1,34

8 1,75 1,88 1,67 1,56 1,50 1,45 1,41 1,38 1,36 1,34

9 1,78 1,90 1,68 1,57 1,50 1,45 1,42 1,39 1,36 1,35

10 1,80 1,90 1,68 1,57 1,50 1,46 1,42 1,39 1,37 1,35

Based on Table 1, the maximum absolute value for Mandel’s h-statistic is 1,71 for the PT serum and the PT milk (p=7). For the PT serum, the maximum value for Mandel’s k-statistic is 1,66 for the reference serum samples PT2013PTUSERNS1, PT2013PTUSERNS2, PT2013PTUSERNS3 and PT2013PTUSERPS1 (p=7 and n=3), and 1,55 for the reference serum samples PT2013PTUSERPS2 and PT2013PTUSERPS3 (p=7 and n=4). For the PT milk, the maximum value for Mandel’s k-statistic is 1,66 for the reference milk samples PT2013PTUSERNM1, PT2013PTUSERNM2, PT2013PTUSERNM3 and PT2013PTUSERPM1 and 1,55 for the reference milk samples PT2013PTUSERPM2 and PT2013PTUSERPM3 (p=7 and n=4). For the detection of PTU-specific antibodies in serum, 6 out of 7 participating laboratories (LAB1,LAB3,LAB4,LAB5, LAB6, LAB7) obtained a satisfactory between-laboratory consistency for all reference serum samples: In contrast, LAB2 showed an increased value for Mandel’s h-statistic for the positive reference serum samples PT2013PTUSERPS1 (h=-2,24). Furthermore, 5 out of 7 participating laboratories obtained a satisfactory within-laboratory consistency for all reference serum samples: LAB2, LAB3, LAB4,LAB5 and LAB7. LAB 1 showed an increased increased value for Mandel’s k-statistic for the reference serum sample PT2013PTUSERNS3 (k=1,92) and LAB6 for the sample PT2013PTUSERNS1 (k=1,81). : For the detection of PTU-specific antibodies in milk, 5 out of six participating and analysed laboratories obtained a satisfactory between-laboratory consistency for all reference milk samples. LAB4 and LAB8 had an increased value for respectively sample PT2013PTUSERNM2 (h= -1,73) and PT2013PTUSERPM1(h= +1,76). Only 2 out of 6 participating and analysed laboratories obtained a satisfactory within-laboratory consistency for all reference milk samples: LAB3 and LAB4. The other participants showed an increased value for Mandel’s k-statistic for at least 1 reference milk sample: LAB10 for the negative reference milk samples PT2013PTUSERNM1 (k=1,97) and PT2013PTUSERNM3 (k= 2,15) and for the positive reference milk sample PT2013PTUSERPM3 (k=1,76), LAB1 for the sample PT2013PTUSERPM2 (k=1,57), LAB9 for the negative reference milk samples PT2013PTUSERNM2 (k=1,72) and LAB8 for the positive reference milk sample PT2013PTUSERPM1 (k=1,67). All data used for the calculations of Mandel’s h- and k-statistics can be found in Annex 2. III. ANOVA Using a SAS macro encoding a general linear model (GLM) with laboratories as fixed effect and the normalized OD values (in this case the percentages S/P ratio) as a dependent variable, it was investigated whether statistically significant differences exist (α=0,05) between participating laboratories. Comparisons were made at the global level (all reference serum samples were analysed together), status level (all reference serum samples with the same status were analysed together) and sample level (all reference serum samples were analysed individually). Since comparing quantitative results between participants or methods (e.g. different kits, batches or incubation protocols) is most relevant at the status level (less variation than at a global level), we focused on the latter. Remark: Because LAB2 calculated percentages S/P ratio using a weak positive kit control, it obtained percentages S/P ratio that were much higher compared to the other partipating laboratories, which used a strong positive kit control. In



order to avoid bias of the comparative quantitative data analysis, data from LAB2 were not included in the ANOVA for the PT milk. For the PT serum, no statistically significant differences were observed at a global level. Nevertheless, statistically significant differences exist at both sample level and status level. At the status level, significant differences were observed for both the negative and the positive (incl. positive/non-interpretable) reference serum samples. For the negative reference serum samples, LAB1 and LAB3 reported percentages S/P ratio that were significantly higher than those reported by LAB5.. For all the positive reference serum samples taken together no statistical differences were found between the laboratories. However, for sample PT2013PTUSERNS1, LAB1, LAB4 and LAB7 clearly reported lower S/P ratio’s compared to LAB5 while this was not the case for samples PT2013PTUSERNS2 and PT2013PTUSERNS3. For the PT milk, statistically significant differences were observed between laboratories at a global level if LAB2 was kept in the analysis. LAB2 significantly reported higher S/P ratio’s than other labs. When LAB2 was left out the analysis then no statistical significant differences were observed at global level. At status level however, it was observed that for the negative reference milk samplesLAB8 and LAB4 reported significantly lower S/P ratio’s compared to the other laboratories. No statistical differences were found between the laboratories for all the positive samples together. For sample PT2013PTUSERPM1, LAB8 clearly reported higher S/P ratio’s than the other laboratories while this was not the case for sample PT2013PTUSERPM2 and PT2013PTUSERPM3.



Annex 2: Calculations of Mandel’s h- and k-statisti cs (based on % S/P ratio) A. Serum PT2013PTU

Sample Labnr n_i v_i x_i_m x_g_m between_lab_coeff STDEV_repeat STDEV_repro STDEV_betweenlab h k cv

PT2013PTUSERNS1 1 3 0,99 9,85 5,80 0,86 0,77 2,04 1,89 0,87 1,30 10,10

PT2013PTUSERNS1 2 3 0,25 2,29 5,80 0,86 0,77 2,04 1,89 -0,76 0,65 21,84

PT2013PTUSERNS1 3 3 0,36 11,02 5,80 0,86 0,77 2,04 1,89 1,12 0,78 5,41

PT2013PTUSERNS1 4 3 0,48 2,54 5,80 0,86 0,77 2,04 1,89 -0,70 0,91 27,36

PT2013PTUSERNS1 5 3 0,08 -1,22 5,80 0,86 0,77 2,04 1,89 -1,51 0,37 -23,17

PT2013PTUSERNS1 6 3 1,93 9,39 5,80 0,86 0,77 2,04 1,89 0,77 1,81 14,80

PT2013PTUSERNS1 7 3 0,03 6,76 5,80 0,86 0,77 2,04 1,89 0,20 0,24 2,73

PT2013PTUSERNS2 1 3 8,40 18,80 10,99 0,79 1,66 3,61 3,21 0,99 1,74 15,42

PT2013PTUSERNS2 2 3 0,00 2,83 10,99 0,79 1,66 3,61 3,21 -1,03 0,03 2,04

PT2013PTUSERNS2 3 3 6,95 20,92 10,99 0,79 1,66 3,61 3,21 1,25 1,59 12,60

PT2013PTUSERNS2 4 3 0,62 12,42 10,99 0,79 1,66 3,61 3,21 0,18 0,47 6,35

PT2013PTUSERNS2 5 3 0,01 -1,04 10,99 0,79 1,66 3,61 3,21 -1,52 0,05 -7,18

PT2013PTUSERNS2 6 3 2,18 10,40 10,99 0,79 1,66 3,61 3,21 -0,07 0,89 14,21

PT2013PTUSERNS2 7 3 1,19 12,63 10,99 0,79 1,66 3,61 3,21 0,21 0,66 8,65

PT2013PTUSERNS3 1 3 2,64 8,73 5,29 0,72 0,85 1,60 1,36 1,03 1,92 18,61

PT2013PTUSERNS3 2 3 0,61 7,30 5,29 0,72 0,85 1,60 1,36 0,60 0,92 10,70

PT2013PTUSERNS3 3 3 0,03 6,83 5,29 0,72 0,85 1,60 1,36 0,46 0,20 2,51

PT2013PTUSERNS3 4 3 0,07 1,18 5,29 0,72 0,85 1,60 1,36 -1,22 0,31 22,21

PT2013PTUSERNS3 5 3 0,62 0,07 5,29 0,72 0,85 1,60 1,36 -1,55 0,93 1061,44

PT2013PTUSERNS3 6 3 0,94 7,58 5,29 0,72 0,85 1,60 1,36 0,68 1,14 12,76

PT2013PTUSERNS3 7 3 0,10 5,34 5,29 0,72 0,85 1,60 1,36 0,01 0,37 5,83

PT2013PTUSERPS1 1 3 8,52 169,72 242,40 0,96 10,77 55,06 53,99 -0,55 0,27 1,72

PT2013PTUSERPS1 2 3 286,94 539,26 242,40 0,96 10,77 55,06 53,99 2,24 1,57 3,14



PT2013PTUSERPS1 3 3 130,39 197,72 242,40 0,96 10,77 55,06 53,99 -0,34 1,06 5,78

PT2013PTUSERPS1 4 3 84,68 171,57 242,40 0,96 10,77 55,06 53,99 -0,53 0,85 5,36

PT2013PTUSERPS1 5 3 200,19 222,67 242,40 0,96 10,77 55,06 53,99 -0,15 1,31 6,35

PT2013PTUSERPS1 6 3 0,95 212,27 242,40 0,96 10,77 55,06 53,99 -0,23 0,09 0,46

PT2013PTUSERPS1 7 3 100,78 183,57 242,40 0,96 10,77 55,06 53,99 -0,44 0,93 5,47

PT2013PTUSERPS2 1 4 42,33 122,28 95,41 0,90 5,96 18,78 17,81 0,61 1,09 5,32

PT2013PTUSERPS2 2 4 37,18 144,82 95,41 0,90 5,96 18,78 17,81 1,13 1,02 4,21

PT2013PTUSERPS2 3 4 49,56 59,33 95,41 0,90 5,96 18,78 17,81 -0,83 1,18 11,86

PT2013PTUSERPS2 4 4 1,30 63,70 95,41 0,90 5,96 18,78 17,81 -0,73 0,19 1,79

PT2013PTUSERPS2 5 4 24,09 35,94 95,41 0,90 5,96 18,78 17,81 -1,36 0,82 13,66

PT2013PTUSERPS2 6 4 53,12 145,04 95,41 0,90 5,96 18,78 17,81 1,14 1,22 5,02

PT2013PTUSERPS2 7 4 40,67 96,75 95,41 0,90 5,96 18,78 17,81 0,03 1,07 6,59

PT2013PTUSERPS3 1 4 88,44 119,52 105,65 0,79 6,24 13,49 11,96 0,47 1,51 7,87

PT2013PTUSERPS3 2 4 13,28 128,51 105,65 0,79 6,24 13,49 11,96 0,78 0,58 2,84

PT2013PTUSERPS3 3 4 59,11 67,48 105,65 0,79 6,24 13,49 11,96 -1,30 1,23 11,39

PT2013PTUSERPS3 4 4 16,01 92,88 105,65 0,79 6,24 13,49 11,96 -0,43 0,64 4,31

PT2013PTUSERPS3 5 4 36,45 73,70 105,65 0,79 6,24 13,49 11,96 -1,08 0,97 8,19

PT2013PTUSERPS3 6 4 12,47 148,60 105,65 0,79 6,24 13,49 11,96 1,46 0,57 2,38

PT2013PTUSERPS3 7 4 46,84 108,92 105,65 0,79 6,24 13,49 11,96 0,11 1,10 6,28

Legend: Labnr = number attributed to a laboratory during the PT; n_i = number of replicates; v_i = total variability (variance) in the normalised data (% S/P); x_i_m = mean of normalized data (% S/P); x_g_m = mean of normalized data (% S/P) obtained by all laboratories; between_lab_coeff = fraction of total variability due to differences between labs for each sample; STDEV_repeat = repeatability standard deviation over all laboratories; STDEV_repro = reproducibility standard deviation over all laboratories; STDEV_betweenlab = between-lab standard deviation over all laboratories; h-statistic = between-laboratory consistency; k-statistic = within-laboratory consistency; CV = variation coefficient in %. Values for Mandel’s h- and k-statistics shown in red/underlined/bold exceed the corresponding limit value as determined in

Annex 1 (Table 1).



B. Milk PT2013PTU

Sample Labnr n_i v_i x_i_m x_g_m between_lab_coeff STDEV_repeat STDEV_repro STDEV_betweenlab h k cv

PT2013PTUSERNM1 1 3 0,01 -0,24 -1,29 0,60 0,61 0,96 0,75 0,61 0,17 -43,48

PT2013PTUSERNM1 3 3 0,00 -0,44 -1,29 0,60 0,61 0,96 0,75 0,50 0,00 0,00

PT2013PTUSERNM1 4 3 0,10 -3,86 -1,29 0,60 0,61 0,96 0,75 -1,51 0,51 -8,10

PT2013PTUSERNM1 8 3 0,33 -2,79 -1,29 0,60 0,61 0,96 0,75 -0,88 0,95 -20,69

PT2013PTUSERNM1 9 3 0,33 0,67 -1,29 0,60 0,61 0,96 0,75 1,15 0,95 86,60

PT2013PTUSERNM1 10 3 1,44 -1,06 -1,29 0,60 0,61 0,96 0,75 0,13 1,97 -112,81

PT2013PTUSERNM2 1 3 0,02 -0,30 -1,33 0,63 0,58 0,95 0,76 0,60 0,24 -45,85

PT2013PTUSERNM2 3 3 0,02 -0,37 -1,33 0,63 0,58 0,95 0,76 0,56 0,25 -40,05

PT2013PTUSERNM2 4 3 0,01 -4,31 -1,33 0,63 0,58 0,95 0,76 -1,73 0,21 -2,80

PT2013PTUSERNM2 8 3 0,81 -2,54 -1,33 0,63 0,58 0,95 0,76 -0,70 1,55 -35,46

PT2013PTUSERNM2 9 3 1,00 0,00 -1,33 0,63 0,58 0,95 0,76 0,77 1,72

PT2013PTUSERNM2 10 3 0,16 -0,48 -1,33 0,63 0,58 0,95 0,76 0,50 0,68 -82,96

PT2013PTUSERNM3 1 3 0,00 -0,12 -1,54 0,70 0,51 0,94 0,79 0,80 0,10 -42,94

PT2013PTUSERNM3 3 3 0,25 -0,34 -1,54 0,70 0,51 0,94 0,79 0,67 0,97 -145,78

PT2013PTUSERNM3 4 3 0,01 -4,31 -1,54 0,70 0,51 0,94 0,79 -1,55 0,23 -2,80

PT2013PTUSERNM3 8 3 0,10 -3,07 -1,54 0,70 0,51 0,94 0,79 -0,86 0,61 -10,27

PT2013PTUSERNM3 9 3 0,00 0,00 -1,54 0,70 0,51 0,94 0,79 0,87 0,00 PT2013PTUSERNM3 10 3 1,22 -1,41 -1,54 0,70 0,51 0,94 0,79 0,07 2,15 -78,34

PT2013PTUSERPM1 1 3 0,11 151,86 162,08 0,71 7,99 14,78 12,44 -0,36 0,04 0,22

PT2013PTUSERPM1 3 3 0,62 130,35 162,08 0,71 7,99 14,78 12,44 -1,13 0,10 0,60

PT2013PTUSERPM1 4 3 36,48 171,71 162,08 0,71 7,99 14,78 12,44 0,34 0,76 3,52

PT2013PTUSERPM1 8 3 177,33 211,69 162,08 0,71 7,99 14,78 12,44 1,76 1,67 6,29

PT2013PTUSERPM1 9 3 30,33 162,33 162,08 0,71 7,99 14,78 12,44 0,01 0,69 3,39

PT2013PTUSERPM1 10 3 138,10 144,51 162,08 0,71 7,99 14,78 12,44 -0,62 1,47 8,13

PT2013PTUSERPM2 1 4 36,64 92,82 53,16 0,91 3,87 13,26 12,69 1,39 1,57 6,52

PT2013PTUSERPM2 3 4 23,91 60,22 53,16 0,91 3,87 13,26 12,69 0,25 1,26 8,12

PT2013PTUSERPM2 4 4 11,71 60,07 53,16 0,91 3,87 13,26 12,69 0,24 0,88 5,70



PT2013PTUSERPM2 8 4 0,93 16,85 53,16 0,91 3,87 13,26 12,69 -1,28 0,25 5,73

PT2013PTUSERPM2 9 4 10,92 65,75 53,16 0,91 3,87 13,26 12,69 0,44 0,85 5,03

PT2013PTUSERPM2 10 4 5,65 23,25 53,16 0,91 3,87 13,26 12,69 -1,05 0,61 10,22

PT2013PTUSERPM3 1 4 10,48 58,57 39,01 0,69 3,90 7,00 5,81 1,49 0,83 5,53

PT2013PTUSERPM3 3 4 2,54 27,24 39,01 0,69 3,90 7,00 5,81 -0,90 0,41 5,85

PT2013PTUSERPM3 4 4 14,39 50,57 39,01 0,69 3,90 7,00 5,81 0,88 0,97 7,50

PT2013PTUSERPM3 8 4 13,89 25,15 39,01 0,69 3,90 7,00 5,81 -1,06 0,96 14,82

PT2013PTUSERPM3 9 4 3,00 36,50 39,01 0,69 3,90 7,00 5,81 -0,19 0,44 4,75

PT2013PTUSERPM3 10 4 47,05 36,03 39,01 0,69 3,90 7,00 5,81 -0,23 1,76 19,04

Legend: Labnr = number attributed to a laboratory during the PT; n_i = number of replicates; v_i = total variability (variance) in the normalised data (% S/P); x_i_m = mean of normalized data (% S/P); x_g_m = mean of normalized data (% S/P) obtained by all laboratories; between_lab_coeff = fraction of total variability due to differences between labs for each sample; STDEV_repeat = repeatability standard deviation over all laboratories; STDEV_repro = reproducibility standard deviation over all laboratories; STDEV_betweenlab = between-lab standard deviation over all laboratories; h-statistic = between-laboratory consistency; k-statistic = within-laboratory consistency; CV = variation coefficient in %. Values for Mandel’s h- and k-statistics shown in red/underlined/bold exceed the corresponding limit value as determined in

Annex 1 (Table 1).

Documents

PROFICIENCY TESTING 2013 - FAVV-AFSCA€¦ · CODACODA- ---CERVACERVA 172-PT PT2013PTUSER 2/24 This report can’t be reproduced, except in complete form, without the permission of